ID   CSRP3_RAT               Reviewed;         194 AA.
AC   P50463;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   29-MAY-2024, entry version 143.
DE   RecName: Full=Cysteine and glycine-rich protein 3;
DE   AltName: Full=Cysteine-rich protein 3;
DE            Short=CRP3;
DE   AltName: Full=LIM domain protein, cardiac;
DE   AltName: Full=Muscle LIM protein;
GN   Name=Csrp3; Synonyms=Clp, Mlp;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   STRAIN=Lewis; TISSUE=Skeletal muscle;
RX   PubMed=7954791; DOI=10.1016/0092-8674(94)90192-9;
RA   Arber S., Halder G., Caroni P.;
RT   "Muscle LIM protein, a novel essential regulator of myogenesis, promotes
RT   myogenic differentiation.";
RL   Cell 79:221-231(1994).
RN   [2]
RP   FUNCTION, INTERACTION WITH MYOD1; MYOG AND MYF6, AND SUBCELLULAR LOCATION.
RX   PubMed=9234731; DOI=10.1128/mcb.17.8.4750;
RA   Kong Y., Flick M.J., Kudla A.J., Konieczny S.F.;
RT   "Muscle LIM protein promotes myogenesis by enhancing the activity of
RT   MyoD.";
RL   Mol. Cell. Biol. 17:4750-4760(1997).
RN   [3]
RP   INTERACTION WITH SPTB.
RX   PubMed=10751147; DOI=10.1242/jcs.113.9.1553;
RA   Flick M.J., Konieczny S.F.;
RT   "The muscle regulatory and structural protein MLP is a cytoskeletal binding
RT   partner of betaI-spectrin.";
RL   J. Cell Sci. 113:1553-1564(2000).
RN   [4]
RP   INTERACTION WITH LDHD.
RX   PubMed=12127981; DOI=10.1016/s0006-291x(02)00768-4;
RA   Flick M.J., Konieczny S.F.;
RT   "Identification of putative mammalian D-lactate dehydrogenase enzymes.";
RL   Biochem. Biophys. Res. Commun. 295:910-916(2002).
RN   [5]
RP   SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=16963613; DOI=10.1152/ajpheart.00766.2006;
RA   Boateng S.Y., Belin R.J., Geenen D.L., Margulies K.B., Martin J.L.,
RA   Hoshijima M., de Tombe P.P., Russell B.;
RT   "Cardiac dysfunction and heart failure are associated with abnormalities in
RT   the subcellular distribution and amounts of oligomeric muscle LIM
RT   protein.";
RL   Am. J. Physiol. 292:H259-269(2007).
RN   [6]
RP   INTERACTION WITH GLRX3.
RX   PubMed=18258855; DOI=10.1161/circresaha.107.165985;
RA   Jeong D., Kim J.M., Cha H., Oh J.G., Park J., Yun S.H., Ju E.S., Jeon E.S.,
RA   Hajjar R.J., Park W.J.;
RT   "PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT
RT   signaling.";
RL   Circ. Res. 102:711-719(2008).
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=19376126; DOI=10.1016/j.yjmcc.2009.04.006;
RA   Boateng S.Y., Senyo S.E., Qi L., Goldspink P.H., Russell B.;
RT   "Myocyte remodeling in response to hypertrophic stimuli requires
RT   nucleocytoplasmic shuttling of muscle LIM protein.";
RL   J. Mol. Cell. Cardiol. 47:426-435(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Positive regulator of myogenesis. Acts as a cofactor for
CC       myogenic bHLH transcription factors such as MYOD1, and probably MYOG
CC       and MYF6. Enhances the DNA-binding activity of the MYOD1:TCF3 isoform
CC       E47 complex and may promote formation of a functional MYOD1:TCF3
CC       isoform E47:MEF2A complex involved in myogenesis (PubMed:7954791,
CC       PubMed:9234731). Plays a crucial and specific role in the organization
CC       of cytosolic structures in cardiomyocytes. Could play a role in
CC       mechanical stretch sensing. May be a scaffold protein that promotes the
CC       assembly of interacting proteins at Z-line structures. It is essential
CC       for calcineurin anchorage to the Z line. Required for stress-induced
CC       calcineurin-NFAT activation. The role in regulation of cytoskeleton
CC       dynamics by association with CFL2 is reported conflictingly. Proposed
CC       to contribute to the maintenance of muscle cell integrity through an
CC       actin-based mechanism. Can directly bind to actin filaments, cross-link
CC       actin filaments into bundles without polarity selectivity and protect
CC       them from dilution- and cofilin-mediated depolymerization; the function
CC       seems to involve its self-association. In vitro can inhibit PKC/PRKCA
CC       activity. Proposed to be involved in cardiac stress signaling by down-
CC       regulating excessive PKC/PRKCA signaling (By similarity).
CC       {ECO:0000250|UniProtKB:P50461, ECO:0000250|UniProtKB:P50462,
CC       ECO:0000269|PubMed:7954791, ECO:0000269|PubMed:9234731}.
CC   -!- SUBUNIT: Self-associates. Oligomeric in the cytoplasm and monomeric in
CC       the nucleus (PubMed:16963613). Homooligomers preferentially form along
CC       the actin cytoskeleton (By similarity). Interacts with TCAP, ACTN2 and
CC       NRAP (By similarity). Interacts with LDHD, SPTB, MYOD1, MYOG, MYF6.
CC       Interacts with GLRX3 (via C-terminus); GLRX3 and calcineurin compete
CC       for interaction with CSRP3 (PubMed:10751147, PubMed:12127981,
CC       PubMed:18258855, PubMed:9234731). Interacts with CFL2; the
CC       stoichiometry influences F-actin depolymerization and possibly two
CC       molecules of CFL2 can interact with one molecule of CSRP3 resulting in
CC       the highest functional impact; the interaction is stronger with
CC       phosphorylated CFL2 (By similarity). {ECO:0000250|UniProtKB:P50461,
CC       ECO:0000269|PubMed:10751147, ECO:0000269|PubMed:12127981,
CC       ECO:0000269|PubMed:16963613, ECO:0000269|PubMed:18258855,
CC       ECO:0000269|PubMed:9234731}.
CC   -!- INTERACTION:
CC       P50463; P10085: Myod1; Xeno; NbExp=3; IntAct=EBI-12502290, EBI-4405734;
CC       P50463; P11277: SPTB; Xeno; NbExp=6; IntAct=EBI-12502290, EBI-514908;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16963613,
CC       ECO:0000269|PubMed:19376126, ECO:0000269|PubMed:9234731}. Cytoplasm
CC       {ECO:0000269|PubMed:16963613, ECO:0000269|PubMed:19376126,
CC       ECO:0000269|PubMed:9234731}. Cytoplasm, cytoskeleton. Cytoplasm,
CC       myofibril, sarcomere, Z line {ECO:0000250|UniProtKB:P50462}. Cytoplasm,
CC       myofibril, sarcomere {ECO:0000250|UniProtKB:P50461}.
CC       Note=Nucleocytoplasmic shuttling protein (PubMed:19376126). Mainly
CC       cytoplasmic. In the Z line, found associated with GLRX3 (By
CC       similarity). {ECO:0000250|UniProtKB:P50462,
CC       ECO:0000269|PubMed:19376126}.
CC   -!- TISSUE SPECIFICITY: High in striated muscle and adult heart.
CC   -!- DOMAIN: LIM zinc-binding domain 1 is required for self-association. LIM
CC       zinc-binding domain 1 and LIM zinc-binding domain 2 both are required
CC       for optimal actin-bundling activity (By similarity). LIM zinc-binding
CC       domain 1 mediates binding to MYOD1. LIM zinc-binding domain 2 mediates
CC       binding to SPTB (PubMed:10751147, PubMed:9234731).
CC       {ECO:0000250|UniProtKB:P50461, ECO:0000269|PubMed:10751147,
CC       ECO:0000269|PubMed:9234731}.
CC   -!- PTM: Phosphorylated by PKC/PRKCA. {ECO:0000250|UniProtKB:P50461}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X81193; CAA57065.1; -; mRNA.
DR   PIR; A55099; A55099.
DR   RefSeq; NP_476485.1; NM_057144.1.
DR   AlphaFoldDB; P50463; -.
DR   SMR; P50463; -.
DR   IntAct; P50463; 5.
DR   STRING; 10116.ENSRNOP00000019310; -.
DR   iPTMnet; P50463; -.
DR   PhosphoSitePlus; P50463; -.
DR   PaxDb; 10116-ENSRNOP00000019310; -.
DR   GeneID; 117505; -.
DR   KEGG; rno:117505; -.
DR   UCSC; RGD:71092; rat.
DR   AGR; RGD:71092; -.
DR   CTD; 8048; -.
DR   RGD; 71092; Csrp3.
DR   eggNOG; KOG1700; Eukaryota.
DR   InParanoid; P50463; -.
DR   OrthoDB; 7294at2759; -.
DR   PhylomeDB; P50463; -.
DR   PRO; PR:P50463; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0030018; C:Z disc; IDA:BHF-UCL.
DR   GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW.
DR   GO; GO:0042805; F:actinin binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0043426; F:MRF binding; IDA:MGI.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; IPI:MGI.
DR   GO; GO:0008307; F:structural constituent of muscle; ISO:RGD.
DR   GO; GO:0031433; F:telethonin binding; ISO:RGD.
DR   GO; GO:0001974; P:blood vessel remodeling; IEP:RGD.
DR   GO; GO:0060048; P:cardiac muscle contraction; ISO:RGD.
DR   GO; GO:0003300; P:cardiac muscle hypertrophy; ISO:RGD.
DR   GO; GO:0048738; P:cardiac muscle tissue development; ISO:RGD.
DR   GO; GO:0055003; P:cardiac myofibril assembly; ISO:RGD.
DR   GO; GO:0035995; P:detection of muscle stretch; ISO:RGD.
DR   GO; GO:0042593; P:glucose homeostasis; ISO:RGD.
DR   GO; GO:0007507; P:heart development; ISO:RGD.
DR   GO; GO:0006954; P:inflammatory response; ISO:RGD.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; ISO:RGD.
DR   GO; GO:0006874; P:intracellular calcium ion homeostasis; ISO:RGD.
DR   GO; GO:0046716; P:muscle cell cellular homeostasis; ISO:RGD.
DR   GO; GO:0007517; P:muscle organ development; IEA:UniProtKB-KW.
DR   GO; GO:0060537; P:muscle tissue development; IBA:GO_Central.
DR   GO; GO:0051091; P:positive regulation of DNA-binding transcription factor activity; IDA:MGI.
DR   GO; GO:0010831; P:positive regulation of myotube differentiation; IDA:MGI.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0070528; P:protein kinase C signaling; ISO:RGD.
DR   GO; GO:0033365; P:protein localization to organelle; ISO:RGD.
DR   GO; GO:1903076; P:regulation of protein localization to plasma membrane; ISO:RGD.
DR   GO; GO:0002026; P:regulation of the force of heart contraction; ISO:RGD.
DR   GO; GO:0045214; P:sarcomere organization; IBA:GO_Central.
DR   GO; GO:0033292; P:T-tubule organization; ISO:RGD.
DR   CDD; cd09481; LIM1_CRP3; 1.
DR   Gene3D; 2.10.110.10; Cysteine Rich Protein; 2.
DR   InterPro; IPR001781; Znf_LIM.
DR   PANTHER; PTHR24215:SF1; CYSTEINE AND GLYCINE-RICH PROTEIN 3; 1.
DR   PANTHER; PTHR24215; RHO-GTPASE-ACTIVATING PROTEIN LRG1; 1.
DR   Pfam; PF00412; LIM; 2.
DR   SMART; SM00132; LIM; 2.
DR   SUPFAM; SSF57716; Glucocorticoid receptor-like (DNA-binding domain); 4.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 2.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 2.
PE   1: Evidence at protein level;
KW   Actin-binding; Cytoplasm; Cytoskeleton; Developmental protein;
KW   Differentiation; LIM domain; Metal-binding; Myogenesis; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Zinc.
FT   CHAIN           1..194
FT                   /note="Cysteine and glycine-rich protein 3"
FT                   /id="PRO_0000075729"
FT   DOMAIN          10..61
FT                   /note="LIM zinc-binding 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   DOMAIN          120..171
FT                   /note="LIM zinc-binding 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   REGION          1..5
FT                   /note="Interaction with TCAP"
FT                   /evidence="ECO:0000250|UniProtKB:P50461"
FT   REGION          94..105
FT                   /note="Interaction with CLF2"
FT                   /evidence="ECO:0000250|UniProtKB:P50461"
FT   MOTIF           64..69
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:19376126"
FT   MOD_RES         95
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P50462"
FT   MOD_RES         111
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P50462"
FT   MOD_RES         153
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   194 AA;  20803 MW;  2D6848C271BA7EAB CRC64;
     MPNWGGGAKC GACDKTVYHA EEIQCNGRSF HKTCFHCMAC RKALDSTTVA AHESEIYCKV
     CYGRKYGPKG IGFGQGAGCL STDTGEHLGL QFQQSPKPAR AATTSNPSKF SAKFGESEKC
     PRCGKSVYAA EKVMGGGKPW HKTCFPCAIC GKSLESTNVT DKDGELYCKV CYAKNFGPTG
     IGFGGLTHQV EKKE
//
